Date lodged: 29 September 2017
To ask the Scottish Government what its position is on the effectiveness of the protein blood test (cMyC) for people who have experienced a suspected heart attack, and whether it is considering rolling this out.
Answered by: Shona Robison 25 October 2017
Scotland's approach continues to be to promote best clinical practice based on current evidence as outlined by Scottish Intercollegiate Guidelines Network (SIGN) guidelines. SIGN No. 148 Acute Coronary Syndrome makes recommendations on the use of appropriate diagnostic tests for cardiac events.
The cMyC test is currently the subject of research that will contribute to the emerging evidence base, which is in its early stages. Consideration of the introduction of new diagnostic tests is informed by advice and evidence-based recommendations made by the Diagnostic Steering Group, working in partnership with Healthcare Improvement Scotland, the Scottish Health Technology Group and Scottish Medicines Consortium.